Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors

Noboru Yamamoto, Tomohide Tamura, Yoshikazu Kamiya, Hiroyuki Ono, Hitoshi Kondoh, Kuniaki Shirao, Yasuhiro Matsumura, Yusuke Tanigawara, Yasuhiro Shimada

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences